Farallon Capital Management
Latest statistics and disclosures from Farallon Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, IWM, UNH, CRM, IQV, and represent 37.31% of Farallon Capital Management's stock portfolio.
- Added to shares of these 10 stocks: IWM (+$862M), AON (+$365M), DIS (+$356M), CRM (+$256M), MRNA (+$154M), RVMD (+$87M), BEAM (+$80M), AZN (+$74M), AMGN (+$73M), EDU (+$66M).
- Started 19 new stock positions in DYN, IMVT, IWM, CRSP, GMED, VEEV, INSM, TECX, FLUT, TMDX. DIS, NUVWQ, AMGN, MRUS, TWST, NRIX, MRNA, CGC, BDSX.
- Reduced shares in these 10 stocks: SPY (-$1.4B), Pioneer Natural Resources (-$924M), GOOG (-$283M), , INSP (-$135M), WAB (-$121M), VSTS (-$95M), GBTC (-$85M), HWM (-$68M), NYT (-$65M).
- Sold out of its positions in ACHC, Aeon Biopharma I, BABA, ALNY, Alpine Immune Sciences, APGE, AVBP, ASND, BRKR, CSGP.
- Farallon Capital Management was a net seller of stock by $-1.4B.
- Farallon Capital Management has $21B in assets under management (AUM), dropping by -4.10%.
- Central Index Key (CIK): 0000909661
Tip: Access up to 7 years of quarterly data
Positions held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 156 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 22.9 | $4.8B | -22% | 8.9M | 544.22 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 4.1 | $862M | NEW | 4.3M | 202.89 |
|
| UnitedHealth (UNH) | 3.9 | $824M | -4% | 1.6M | 509.26 |
|
| salesforce (CRM) | 3.6 | $758M | +50% | 2.9M | 257.10 |
|
| Iqvia Holdings (IQV) | 2.9 | $618M | +3% | 2.9M | 211.44 |
|
| Exelixis (EXEL) | 2.9 | $609M | 27M | 22.47 |
|
|
| Aramark Hldgs (ARMK) | 2.7 | $576M | -5% | 17M | 34.02 |
|
| Aon Shs Cl A (AON) | 2.6 | $551M | +196% | 1.9M | 293.58 |
|
| Microsoft Corporation (MSFT) | 2.5 | $538M | 1.2M | 446.95 |
|
|
| New York Times Cl A (NYT) | 2.4 | $508M | -11% | 9.9M | 51.21 |
|
| Natera (NTRA) | 2.3 | $483M | +13% | 4.5M | 108.29 |
|
| Ishares Tr Ishares Biotech Put Option (IBB) | 2.3 | $480M | 3.5M | 137.26 |
|
|
| Nasdaq Omx (NDAQ) | 2.1 | $452M | -11% | 7.5M | 60.26 |
|
| Transunion (TRU) | 2.1 | $448M | -4% | 6.0M | 74.16 |
|
| Intuit (INTU) | 2.0 | $413M | +17% | 629k | 657.21 |
|
| Thermo Fisher Scientific (TMO) | 1.9 | $409M | -7% | 739k | 553.00 |
|
| Sarepta Therapeutics Call Option (SRPT) | 1.8 | $384M | 2.4M | 158.00 |
|
|
| Revolution Medicines (RVMD) | 1.8 | $379M | +29% | 9.8M | 38.81 |
|
| Servicenow (NOW) | 1.7 | $357M | +14% | 454k | 786.67 |
|
| Walt Disney Company (DIS) | 1.7 | $356M | NEW | 3.6M | 99.29 |
|
| S&p Global (SPGI) | 1.6 | $349M | 782k | 446.00 |
|
|
| Wabtec Corporation (WAB) | 1.6 | $346M | -25% | 2.2M | 158.05 |
|
| Cbre Group Cl A (CBRE) | 1.6 | $336M | -9% | 3.8M | 89.11 |
|
| Alphabet Cap Stk Cl C (GOOG) | 1.6 | $330M | -46% | 1.8M | 183.42 |
|
| Boston Scientific Corporation (BSX) | 1.5 | $316M | -10% | 4.1M | 77.01 |
|
| Analog Devices (ADI) | 1.4 | $293M | -16% | 1.3M | 228.26 |
|
| Airbnb Com Cl A (ABNB) | 1.2 | $258M | +5% | 1.7M | 151.63 |
|
| Agios Pharmaceuticals (AGIO) | 1.2 | $244M | 5.7M | 43.12 |
|
|
| Visa Com Cl A (V) | 1.0 | $216M | +20% | 822k | 262.47 |
|
| Full Truck Alliance Sponsored Ads (YMM) | 1.0 | $208M | 26M | 8.04 |
|
|
| Mastercard Incorporated Cl A (MA) | 1.0 | $204M | -9% | 463k | 441.16 |
|
| Protagonist Therapeutics (PTGX) | 1.0 | $202M | 5.8M | 34.65 |
|
|
| Howmet Aerospace (HWM) | 0.9 | $197M | -25% | 2.5M | 77.63 |
|
| Sherwin-Williams Company (SHW) | 0.9 | $193M | -14% | 648k | 298.43 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.9 | $188M | +65% | 2.4M | 77.99 |
|
| Beam Therapeutics (BEAM) | 0.9 | $185M | +75% | 7.9M | 23.43 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.9 | $183M | +53% | 2.3M | 80.29 |
|
| Iqiyi Note 4.000%12/1 (Principal) | 0.8 | $162M | 163M | 0.99 |
|
|
| Moderna Put Option (MRNA) | 0.7 | $154M | NEW | 1.3M | 118.75 |
|
| Centene Corporation (CNC) | 0.7 | $144M | -16% | 2.2M | 66.30 |
|
| Masimo Corporation (MASI) | 0.7 | $141M | -24% | 1.1M | 125.94 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 0.5 | $114M | +138% | 1.5M | 77.73 |
|
| Sunrun Note 2/0 (Principal) | 0.5 | $112M | 129M | 0.87 |
|
|
| Tenet Healthcare Corp Com New (THC) | 0.4 | $92M | +7% | 687k | 133.03 |
|
| Longboard Pharmaceuticals In (LBPH) | 0.4 | $80M | 2.9M | 27.03 |
|
|
| Biohaven (BHVN) | 0.4 | $78M | +181% | 2.2M | 34.71 |
|
| Zto Express Cayman Note 1.500% 9/0 (Principal) | 0.3 | $73M | 75M | 0.97 |
|
|
| Amgen (AMGN) | 0.3 | $73M | NEW | 232k | 312.45 |
|
| Geron Corporation (GERN) | 0.3 | $71M | +124% | 17M | 4.24 |
|
| Ke Hldgs Sponsored Ads (BEKE) | 0.3 | $67M | 4.7M | 14.15 |
|
|
| Icon SHS (ICLR) | 0.3 | $56M | 178k | 313.47 |
|
|
| AmerisourceBergen (COR) | 0.3 | $55M | -27% | 243k | 225.30 |
|
| Cerevel Therapeutics Hldng I (CERE) | 0.2 | $49M | +11% | 1.2M | 40.89 |
|
| Silicon Motion Technology Sponsored Adr (SIMO) | 0.2 | $46M | -33% | 568k | 80.99 |
|
| United Therapeutics Corporation (UTHR) | 0.2 | $46M | +30% | 143k | 318.55 |
|
| Insmed Com Par $.01 (INSM) | 0.2 | $38M | NEW | 568k | 67.00 |
|
| Progyny (PGNY) | 0.2 | $37M | +120% | 1.3M | 28.61 |
|
| Flutter Entmt SHS (FLUT) | 0.2 | $37M | NEW | 201k | 182.36 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.1 | $29M | NEW | 530k | 54.01 |
|
| Enanta Pharmaceuticals (ENTA) | 0.1 | $27M | 2.1M | 12.97 |
|
|
| Liquidia Corporation Com New (LQDA) | 0.1 | $25M | 2.1M | 12.00 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 0.1 | $22M | +9840% | 497k | 44.79 |
|
| Vaxcyte (PCVX) | 0.1 | $22M | -23% | 290k | 75.51 |
|
| Savara (SVRA) | 0.1 | $18M | +90% | 4.6M | 4.03 |
|
| Voyager Therapeutics (VYGR) | 0.1 | $18M | 2.3M | 7.91 |
|
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $18M | +438% | 2.0M | 9.03 |
|
| Spyre Therapeutics Com New (SYRE) | 0.1 | $16M | +42% | 666k | 23.51 |
|
| Tal Education Group Sponsored Ads (TAL) | 0.1 | $15M | 1.4M | 10.67 |
|
|
| Zymeworks Del (ZYME) | 0.1 | $14M | 1.6M | 8.51 |
|
|
| PG&E Corporation (PCG) | 0.1 | $12M | -45% | 692k | 17.46 |
|
| GDS HLDGS Sponsored Ads (GDS) | 0.1 | $11M | +72% | 1.2M | 9.29 |
|
| Elevation Oncology (ELEV) | 0.0 | $9.7M | -7% | 3.6M | 2.70 |
|
| Twist Bioscience Corp (TWST) | 0.0 | $9.5M | NEW | 192k | 49.28 |
|
| Rio Tinto Sponsored Adr (RIO) | 0.0 | $9.1M | 138k | 65.93 |
|
|
| Ventyx Biosciences (VTYX) | 0.0 | $7.3M | 3.2M | 2.31 |
|
|
| Roivant Sciences SHS (ROIV) | 0.0 | $7.1M | -25% | 673k | 10.57 |
|
| Tectonic Therapeutic (TECX) | 0.0 | $7.1M | NEW | 431k | 16.47 |
|
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.0 | $6.1M | 600k | 10.22 |
|
|
| Metals Acquisition Ord Shs (MTAL) | 0.0 | $5.6M | +160% | 410k | 13.69 |
|
| Cytokinetics Com New (CYTK) | 0.0 | $5.5M | 102k | 54.18 |
|
|
| Metagenomi (MGX) | 0.0 | $5.5M | 1.3M | 4.08 |
|
|
| Novavax Com New (NVAX) | 0.0 | $4.8M | -66% | 377k | 12.66 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.0 | $4.1M | 99k | 41.10 |
|
|
| Prime Medicine (PRME) | 0.0 | $3.9M | 750k | 5.14 |
|
|
| Cogent Biosciences (COGT) | 0.0 | $3.6M | -7% | 425k | 8.43 |
|
| Swiftmerge Acquisition Corp Class A Ord Shs (IVCP) | 0.0 | $3.3M | 300k | 10.93 |
|
|
| Berenson Acquisition Corp I Cl A Com | 0.0 | $3.0M | 286k | 10.65 |
|
|
| Biodesix (BDSX) | 0.0 | $2.9M | NEW | 1.9M | 1.53 |
|
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $2.3M | 200k | 11.46 |
|
|
| Nurix Therapeutics (NRIX) | 0.0 | $2.3M | NEW | 109k | 20.87 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.0 | $2.2M | 1.2M | 1.90 |
|
|
| Summit Midstream Partners Com Unit Ltd (SMLP) | 0.0 | $2.1M | 58k | 35.56 |
|
|
| Grindr *w Exp 11/18/202 (GRND.WS) | 0.0 | $1.8M | 540k | 3.25 |
|
|
| Marblegate Acquisition Corp Com Cl A (GATE) | 0.0 | $1.6M | 150k | 10.81 |
|
|
| Vnet Group Sponsored Ads A (VNET) | 0.0 | $1.4M | 650k | 2.10 |
|
|
| Quanterix Ord (QTRX) | 0.0 | $1.1M | -83% | 80k | 13.21 |
|
| Forte Biosciences (FBRX) | 0.0 | $972k | 1.8M | 0.54 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $930k | 3.3k | 280.16 |
|
|
| Veeva Sys Cl A Com (VEEV) | 0.0 | $663k | NEW | 3.6k | 183.01 |
|
| Sage Therapeutics (SAGE) | 0.0 | $465k | 43k | 10.86 |
|
|
| Blueprint Medicines (BPMC) | 0.0 | $431k | 4.0k | 107.78 |
|
|
| Cara Therapeutics (CARA) | 0.0 | $402k | 1.6M | 0.26 |
|
|
| Krystal Biotech (KRYS) | 0.0 | $367k | 2.0k | 183.64 |
|
|
| Axsome Therapeutics (AXSM) | 0.0 | $322k | 4.0k | 80.50 |
|
|
| Hca Holdings (HCA) | 0.0 | $321k | 1.0k | 321.28 |
|
|
| Immunovant (IMVT) | 0.0 | $317k | NEW | 12k | 26.40 |
|
| Glaukos (GKOS) | 0.0 | $308k | 2.6k | 118.35 |
|
|
| Transmedics Group (TMDX) | 0.0 | $301k | NEW | 2.0k | 150.62 |
|
| Intuitive Machines *w Exp 99/99/999 (LUNRW) | 0.0 | $299k | 441k | 0.68 |
|
|
| Merit Medical Systems (MMSI) | 0.0 | $258k | 3.0k | 85.95 |
|
|
| Encompass Health Corp (EHC) | 0.0 | $257k | 3.0k | 85.79 |
|
|
| Brightspring Health Svcs (BTSG) | 0.0 | $250k | 22k | 11.36 |
|
|
| Globus Med Cl A (GMED) | 0.0 | $247k | NEW | 3.6k | 68.49 |
|
| Arcutis Biotherapeutics (ARQT) | 0.0 | $242k | -98% | 26k | 9.30 |
|
| Healthequity (HQY) | 0.0 | $241k | 2.8k | 86.20 |
|
|
| Merus N V (MRUS) | 0.0 | $237k | NEW | 4.0k | 59.17 |
|
| Apellis Pharmaceuticals (APLS) | 0.0 | $230k | 6.0k | 38.36 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $229k | -99% | 4.8k | 47.66 |
|
| Humana (HUM) | 0.0 | $224k | -98% | 600.00 | 373.65 |
|
| Arcellx Common Stock (ACLX) | 0.0 | $221k | 4.0k | 55.19 |
|
|
| Chemed Corp Com Stk (CHE) | 0.0 | $217k | 400.00 | 542.58 |
|
|
| Sabra Health Care REIT (SBRA) | 0.0 | $216k | 14k | 15.40 |
|
|
| Dyne Therapeutics (DYN) | 0.0 | $212k | NEW | 6.0k | 35.29 |
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $209k | 26k | 8.02 |
|
|
| Syndax Pharmaceuticals (SNDX) | 0.0 | $205k | 10k | 20.53 |
|
|
| Avidity Biosciences Ord (RNA) | 0.0 | $204k | -99% | 5.0k | 40.85 |
|
| Hims & Hers Health Com Cl A (HIMS) | 0.0 | $202k | -99% | 10k | 20.19 |
|
| R1 RCM (RCM) | 0.0 | $201k | 16k | 12.56 |
|
|
| Canopy Growth Corp Com New (CGC) | 0.0 | $194k | NEW | 30k | 6.45 |
|
| Sdcl Edge Acquisition Corp *w Exp 99/99/999 (SEDA.WS) | 0.0 | $191k | 866k | 0.22 |
|
|
| Pacific Biosciences of California (PACB) | 0.0 | $185k | -96% | 135k | 1.37 |
|
| Altimmune Com New (ALT) | 0.0 | $184k | -94% | 28k | 6.65 |
|
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.0 | $177k | 28k | 6.30 |
|
|
| Oscar Health Cl A (OSCR) | 0.0 | $174k | 11k | 15.82 |
|
|
| Ardelyx (ARDX) | 0.0 | $170k | 23k | 7.41 |
|
|
| Amicus Therapeutics (FOLD) | 0.0 | $159k | 16k | 9.92 |
|
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $129k | 28k | 4.62 |
|
|
| Beyond Meat (BYND) | 0.0 | $128k | 19k | 6.71 |
|
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $85k | 13k | 6.52 |
|
|
| Swiftmerge Acquisition Corp *w Exp 12/13/202 (IVCPW) | 0.0 | $79k | 990k | 0.08 |
|
|
| Churchill Capital Corp Vii *w Exp 02/29/202 (CVIIW) | 0.0 | $70k | 200k | 0.35 |
|
|
| Solid Power *w Exp 12/08/202 (SLDPW) | 0.0 | $65k | 405k | 0.16 |
|
|
| Marblegate Acquisition Corp *w Exp 08/31/202 (GATEW) | 0.0 | $55k | 1.5M | 0.04 |
|
|
| Lufax Holding Sponsored Adr (LU) | 0.0 | $36k | -89% | 15k | 2.37 |
|
| Cartica Acquisition Corp *w Exp 04/30/202 (CITEW) | 0.0 | $34k | 175k | 0.19 |
|
|
| Jaws Mustang Acquisition Cor *w Exp 01/30/202 (JWSM.WS) | 0.0 | $22k | 200k | 0.11 |
|
|
| Gores Holdings Ix *w Exp 01/14/202 (GHIXW) | 0.0 | $18k | 167k | 0.11 |
|
|
| Perception Capital Corp Iv *w Exp 99/99/999 (RCFA.WS) | 0.0 | $16k | 300k | 0.05 |
|
|
| Kensington Capital Acquisiti *w Exp 99/99/999 (KCGI.WS) | 0.0 | $15k | 581k | 0.03 |
|
|
| Blockchain Coinvstrs Acq Crp *w Exp 11/01/202 (BCSAW) | 0.0 | $9.0k | 150k | 0.06 |
|
|
| Nvni Group *w Exp 11/01/202 (NVNIW) | 0.0 | $8.9k | 375k | 0.02 |
|
|
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $8.6k | 120k | 0.07 |
|
|
| Sep Acquisition Corp *w Exp 99/99/999 (SEPAW) | 0.0 | $6.4k | 866k | 0.01 |
|
|
| Slam Corp *w Exp 99/99/999 (SLMWF) | 0.0 | $4.4k | 18k | 0.25 |
|
|
| Holdco Nuvo Group D G *w Exp 05/01/202 (NUVWQ) | 0.0 | $4.3k | NEW | 200k | 0.02 |
|
| Rigetti Computing *w Exp 99/99/999 (RGTIW) | 0.0 | $3.1k | 23k | 0.14 |
|
Past Filings by Farallon Capital Management
SEC 13F filings are viewable for Farallon Capital Management going back to 2010
- Farallon Capital Management 2024 Q2 filed Aug. 14, 2024
- Farallon Capital Management 2024 Q1 amended filed Aug. 14, 2024
- Farallon Capital Management 2024 Q1 restated filed May 24, 2024
- Farallon Capital Management 2024 Q1 filed May 15, 2024
- Farallon Capital Management 2023 Q3 amended filed May 15, 2024
- Farallon Capital Management 2023 Q4 amended filed May 15, 2024
- Farallon Capital Management 2023 Q3 amended filed Feb. 12, 2024
- Farallon Capital Management 2023 Q3 filed Nov. 14, 2023
- Farallon Capital Management 2022 Q1 amended filed Nov. 14, 2023
- Farallon Capital Management 2022 Q2 amended filed Nov. 14, 2023
- Farallon Capital Management 2022 Q3 amended filed Nov. 14, 2023
- Farallon Capital Management 2022 Q4 amended filed Nov. 14, 2023
- Farallon Capital Management 2023 Q1 amended filed Nov. 14, 2023
- Farallon Capital Management 2023 Q2 amended filed Nov. 14, 2023
- Farallon Capital Management 2023 Q2 amended filed Oct. 26, 2023
- Farallon Capital Management 2023 Q2 filed Aug. 14, 2023